Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.
Riccardo MugliaMatteo SimonelliFederico PessinaEmanuela MorenghiPierina NavarriaPasquale PersicoElena LorenziAngelo DipasqualeMarco GrimaldiMarta ScorsettiArmando SantoroLetterio Salvatore PolitiPublished in: European radiology (2020)
• Temporal muscle thickness (TMT) is a surrogate marker of sarcopenia and has been correlated with survival expectancy in patients suffering from brain metastases and recurrent or treated glioblastoma. • We appraised the correlation among TMT and survival, sex, age at surgery, and performance status, measured on brain MRIs of patients affected by glioblastoma at diagnosis. • TMT did not show any significant correlation with prognosis, age at surgery, or performance status, and its usefulness might be restricted only to patients with brain metastases and recurrent or treated glioblastoma.
Keyphrases
- brain metastases
- end stage renal disease
- small cell lung cancer
- newly diagnosed
- skeletal muscle
- ejection fraction
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- acute coronary syndrome
- resting state
- percutaneous coronary intervention
- functional connectivity
- surgical site infection
- subarachnoid hemorrhage
- cerebral ischemia